These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18275779)

  • 21. Postoperative Central Anticholinergic Syndrome: Is it Really that Rare?
    Quang CY; Blair SG; Watson R; Brevard SB; Simmons JD; Tan MC
    Am Surg; 2017 Mar; 83(3):e104-105. PubMed ID: 28316304
    [No Abstract]   [Full Text] [Related]  

  • 22. Central anticholinergic syndrome following dobutamine-atropine stress echocardiography.
    Wilson ME; Lee GK; Chandra A; Kane GC
    Echocardiography; 2011 Nov; 28(10):E205-6. PubMed ID: 21929583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.
    Movig KL; Egberts AC; Lenderink AW; Leufkens HG
    J Am Geriatr Soc; 2001 Feb; 49(2):234-5. PubMed ID: 11207885
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of antiphospholipid antibody in children with Henoch-Schönlein purpura and central nervous system involvement.
    Liu A; Zhang H
    Pediatr Neurol; 2012 Sep; 47(3):167-70. PubMed ID: 22883280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus.
    Alarcón-Segovia D; Estañol B; García-Ramos G; Villa AR
    Ann N Y Acad Sci; 1997 Aug; 823():279-88. PubMed ID: 9292055
    [No Abstract]   [Full Text] [Related]  

  • 26. Early death due to severe organophosphate poisoning is a centrally mediated process.
    Bird SB; Gaspari RJ; Dickson EW
    Acad Emerg Med; 2003 Apr; 10(4):295-8. PubMed ID: 12670839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological manifestations of primary antiphospholipid antibody syndrome: a prospective study.
    Udayakumar N; Venkatesan SA
    J Clin Rheumatol; 2007 Aug; 13(4):238-9. PubMed ID: 17762466
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neurological manifestations of the antiphospholipid syndrome].
    Suárez Alvarez L; Hughes GR; Khamashta MA
    Med Clin (Barc); 2005 Apr; 124(16):630-3. PubMed ID: 15871782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term heavy use of diphenhydramine without anticholinergic delirium.
    Isabelle C; Warner A
    Am J Health Syst Pharm; 1999 Mar; 56(6):555-7. PubMed ID: 10192692
    [No Abstract]   [Full Text] [Related]  

  • 30. [Three episodes of acute multiorgan failure in a woman with secondary antiphospholipid syndrome].
    Undas A; Swadźba J; Undas R; Musiał J
    Pol Arch Med Wewn; 1998 Dec; 100(6):556-60. PubMed ID: 10405569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central anticholinergic syndrome: a case report.
    Moos DD
    J Perianesth Nurs; 2007 Oct; 22(5):309-21. PubMed ID: 17900503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hot, blind, and mad: avoidable geriatric anticholinergic delirium.
    Ochs KL; Zell-Kanter M; Mycyk MB;
    Am J Emerg Med; 2012 Mar; 30(3):514.e1-3. PubMed ID: 21458946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible central anticholinergic syndrome following transdermal scopolamine in an ambulatory surgery patient.
    Norton JA; Khabiri B; Arbona FL; Kover AJ
    Can J Anaesth; 2011 Dec; 58(12):1149-50. PubMed ID: 21989550
    [No Abstract]   [Full Text] [Related]  

  • 34. [A woman with known anxiety, depression and alcohol abuse].
    Brandsaeter B; Sabel M; Rui TO
    Tidsskr Nor Laegeforen; 2010 Feb; 130(4):385-6. PubMed ID: 20220864
    [No Abstract]   [Full Text] [Related]  

  • 35. Limitations of the Anticholinergic Activity Assay and Assay-Based Anticholinergic Drug Scales.
    Mayer T; Kopitz J; Plaschke K; Weiss J; Seidling HM; Haefeli WE
    Am J Geriatr Psychiatry; 2016 Dec; 24(12):1182-1188. PubMed ID: 27743843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid antibody syndrome in a patient with neurosarcoidosis.
    Satti SD; Bartholomew J; Gordon SM; Longworth DL; Adal KA
    Vasc Med; 1999; 4(1):37-9. PubMed ID: 10355869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of neuroleptic malignant syndrome with anticholinergic medication.
    Hasan MY; Schauben JL; Holmes CH
    Vet Hum Toxicol; 1999 Apr; 41(2):79-81. PubMed ID: 10192135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurological manifestations of anti-phospholipid (Hughes) syndrome.
    Antunes MC; D'Cruz D; Hughes GR
    Clin Exp Rheumatol; 2004; 22(6):771-5. PubMed ID: 15638055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The heterogeneity of systemic lupus erythematosus due to the antiphospholipid syndrome].
    Alekberova ZS; Nasonov EL; Stoianovich LZ
    Ter Arkh; 1992; 64(5):77-9. PubMed ID: 1455383
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurological involvement in antiphospholipid antibodies syndrome (APS).
    Amoroso A; Mitterhofer AP; Ferri GM; Galluzzo S; Vadacca M; Afeltra A
    Eur Rev Med Pharmacol Sci; 1999; 3(5):205-9. PubMed ID: 11075618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.